{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:50:16Z","timestamp":1762987816116,"version":"3.45.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T00:00:00Z","timestamp":1606867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI036082","R01AI110553","R01AI150590","UM1AI069452"],"award-info":[{"award-number":["R01AI036082","R01AI110553","R01AI150590","UM1AI069452"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008333","name":"University of Alabama at Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008333","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011221","name":"School of Medicine, University of Alabama at Birmingham","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.xcrm.2020.100164","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T12:26:43Z","timestamp":1607171203000},"page":"100164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency"],"prefix":"10.1016","volume":"2","author":[{"given":"Kazuhito","family":"Honjo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronnie M.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2063-8840","authenticated-orcid":false,"given":"Regina","family":"Stoltz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edlue M.","family":"Tabengwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutao","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Prichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashton N.","family":"Kornbrust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Sterrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6689-7856","authenticated-orcid":false,"given":"Marisa B.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3666-1439","authenticated-orcid":false,"given":"Jose L.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris M.","family":"Lough","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd P.","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Ketas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora","family":"Hatziioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul D.","family":"Bieniasz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Redden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul A.","family":"Goepfert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3826-0954","authenticated-orcid":false,"given":"Sonya L.","family":"Heath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9400-9887","authenticated-orcid":false,"given":"Beatrice H.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1906-8219","authenticated-orcid":false,"given":"Randall S.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2020.100164_bib1","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI138003","article-title":"The convalescent sera option for containing COVID-19","volume":"130","author":"Casadevall","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2020.100164_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/clinids\/21.1.150","article-title":"Return to the past: the case for antibody-based therapies in infectious diseases","volume":"21","author":"Casadevall","year":"1995","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2020.100164_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s10096-004-1271-9","article-title":"Use of convalescent plasma therapy in SARS patients in Hong Kong","volume":"24","author":"Cheng","year":"2005","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.xcrm.2020.100164_bib4","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3201\/eid2209.151164","article-title":"Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia","volume":"22","author":"Arabi","year":"2016","journal-title":"Emerg. Infect. Dis."},{"year":"2020","series-title":"Coronavirus (COVID-19) update: FDA coordinates national effort to develop blood-related therapies for COVID-19","key":"10.1016\/j.xcrm.2020.100164_bib5"},{"key":"10.1016\/j.xcrm.2020.100164_bib6","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.mayocp.2020.06.028","article-title":"Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients","volume":"95","author":"Joyner","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.xcrm.2020.100164_bib7","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.ajpath.2020.05.014","article-title":"Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma","volume":"190","author":"Salazar","year":"2020","journal-title":"Am. J. Pathol."},{"year":"2020","series-title":"Emergency use authorization (EUA) of COVID-19 convalescent plasma for treatment of COVID-19 in hospitalized patients","key":"10.1016\/j.xcrm.2020.100164_bib8"},{"key":"10.1016\/j.xcrm.2020.100164_bib9","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1016\/j.ajpath.2020.08.001","article-title":"Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality","volume":"190","author":"Salazar","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2020.100164_bib10","article-title":"Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience","author":"Joyner","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.xcrm.2020.100164_bib11","article-title":"Convalescent Plasma for COVID-19. A randomized clinical trial","author":"Gharbharan","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.xcrm.2020.100164_bib12","doi-asserted-by":"crossref","first-page":"m3939","DOI":"10.1136\/bmj.m3939","article-title":"Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)","volume":"371","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.xcrm.2020.100164_bib13","article-title":"Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel","author":"Pau","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.xcrm.2020.100164_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2020.100164_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2020.100164_bib16","doi-asserted-by":"crossref","first-page":"e20201181","DOI":"10.1084\/jem.20201181","article-title":"Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses","volume":"217","author":"Schmidt","year":"2020","journal-title":"J.\u00a0Exp. Med."},{"year":"2020","series-title":"Investigational COVID-19 Convalescent Plasma: Guidance for Industry","key":"10.1016\/j.xcrm.2020.100164_bib17"},{"year":"2020","series-title":"Decisional Memo","key":"10.1016\/j.xcrm.2020.100164_bib18"},{"key":"10.1016\/j.xcrm.2020.100164_bib19","article-title":"Use of convalescent serum reduces severity of COVID-19 in nonhuman primates","author":"Cross","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2020.100164_bib20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.cell.2020.06.010","article-title":"Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment","volume":"182","author":"Sun","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2020.100164_bib21","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","volume":"369","author":"Rogers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2020.100164_bib22","article-title":"COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice","author":"Zheng","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2020.100164_bib23","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood.2020006965","article-title":"Outcomes of COVID-19 in patients with CLL: a multicenter international experience","volume":"136","author":"Mato","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2020.100164_bib24","doi-asserted-by":"crossref","first-page":"e57877","DOI":"10.7554\/eLife.57877","article-title":"Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization","volume":"9","author":"Klasse","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2020.100164_bib25","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/infdis\/jiaa505","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019","volume":"222","author":"Bradfute","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2020.100164_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2020.100164_bib27","article-title":"Selecting COVID-19 Convalescent Plasma for Neutralizing Antibody Potency Using a High-capacity SARS-CoV-2 Antibody Assay","author":"Goodhue Meyer","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.xcrm.2020.100164_bib28","doi-asserted-by":"crossref","first-page":"2001260","DOI":"10.2807\/1560-7917.ES.2020.25.28.2001260","article-title":"Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020","volume":"25","author":"Harvala","year":"2020","journal-title":"Euro Surveill."},{"key":"10.1016\/j.xcrm.2020.100164_bib29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial","volume":"324","author":"Li","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.xcrm.2020.100164_bib30","first-page":"ciaa1143","article-title":"Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection","author":"Wang","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2020.100164_bib31","first-page":"ciaa721","article-title":"Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients","author":"Wang","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2020.100164_bib32","article-title":"SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19","author":"Chen","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2020.100164_bib33","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1473-3099(09)70175-6","article-title":"Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses","volume":"9","author":"Kunisaki","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.xcrm.2020.100164_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/ejh.13223","article-title":"Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies","volume":"102","author":"Na","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.xcrm.2020.100164_bib35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2020.100164_bib36","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1126\/science.abe2402","article-title":"REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters","volume":"370","author":"Baum","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2020.100164_bib37","unstructured":"Accelerated emergency use authorization (EUA) summary FRL SARS-CoV-2 Test (UAB Fungal Reference Lab). https:\/\/www.fda.gov\/media\/139437\/download."},{"key":"10.1016\/j.xcrm.2020.100164_bib38","doi-asserted-by":"crossref","first-page":"e00941-20","DOI":"10.1128\/JCM.00941-20","article-title":"Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho","volume":"58","author":"Bryan","year":"2020","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.xcrm.2020.100164_bib39","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.abc5902","article-title":"Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability","volume":"369","author":"Brouwer","year":"2020","journal-title":"Science"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379120302111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379120302111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:45:56Z","timestamp":1762987556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379120302111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2666379120302111"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2020.100164","relation":{},"ISSN":["2666-3791"],"issn-type":[{"type":"print","value":"2666-3791"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2020.100164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100164"}}